Publications by authors named "Fabio Mascella"

Claim this Profile
F
Filgotinib Effectiveness in Rheumatoid Arthritis: Observational Analysis of a Large Multicenter Cohort.
Eleonora Celletti, Myriam Di Penta, Alarico Ariani, Simone Parisi, Romina Andracco, Fabio Mascella

Rheumatol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness of cycling versus swapping to IL-17 inhibitors after first TNF inhibitor failure in Psoriatic Arthritis: A real-world multicenter study.
Alarico Ariani, Maddalena Larosa, Alberto Lo Gullo, Olga Addimanda, Romina Andracco, Fabio Mascella

BMC Rheumatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guselkumab effectiveness in real-world settings: observations from an Italian multicentre study.
Andrea Becciolini, Antonio Marchesoni, Simone Parisi, Alberto Lo Gullo, Olga Addimanda, Fabio Mascella

Rheumatol Adv Pract· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and ultrasonographic predictors of disease activity after TNF-α inhibitor spacing in patients with psoriatic arthritis.
Antonio Marchesoni, Pierluigi Macchioni, Giovanni Ciancio, Gilda Sandri, Alen Zabotti, Fabio Mascella

Joint Bone Spine· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ixekizumab Retention Rate and Predictors of Treatment Persistence in Psoriatic Arthritis: Results of an Italian Multicenter Study.
Camilla Mazzanti, Marino Paroli, Gianluca Santoboni, Olga Addimanda, Bernd Raffeiner, Fabio Mascella

J Psoriasis Psoriatic Arthritis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and Predictors of Long-Term Treatment Response to Tofacitinib in Rheumatoid Arthritis Cohort: General Analysis and Focus on High-Cardiovascular-Risk Subgroup-A Multicenter Study.
Marta Priora, Andrea Becciolini, Eleonora Celletti, Myriam Di Penta, Alberto Lo Gullo, Fabio Mascella

Medicina (Kaunas)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritis.
Alberto Lo Gullo, Simone Parisi, Andrea Becciolini, Marino Paroli, Elena Bravi, Fabio Mascella

Minerva Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of Safety Warnings on the Prescribing Attitude of JAK Inhibitors for Rheumatoid Arthritis in Italy.
Marino Paroli, Andrea Becciolini, Alberto Lo Gullo, Simone Parisi, Elena Bravi, Fabio Mascella

J Clin Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of survival rate and persistence predictors of baricitinib in real-world data from a large cohort of rheumatoid arthritis patients.
Simone Parisi, Becciolini Andrea, Ditto Maria Chiara, Alberto Lo Gullo, Larosa Maddalena, Mascella Fabio

Curr Res Pharmacol Drug Discov· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort Study.
Marino Paroli, Andrea Becciolini, Elena Bravi, Romina Andracco, Valeria Nucera, Fabio Mascella

Medicina (Kaunas)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Residual inflammation in psoriatic arthritis patients in stable minimal disease activity.
Pierluigi Macchioni, Antonio Marchesoni, Giovanni Ciancio, Gilda Sandri, Alen Zabotti, Fabio Mascella

Front Med (Lausanne)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective Desensitization to Tocilizumab in Delayed Hypersensitivity Reaction.
Gabriele Cortellini, Fabio Mascella, Margherita Simoncelli, Domenico Lippolis, Maria Cristina Focherini

Pharmacology· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aromatase inhibitors and anti-synthetase syndrome.
Fabio Mascella, Lorenzo Gianni, Alessandra Affatato, Manuela Fantini

Int J Immunopathol Pharmacol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Methodological problems associated with the planning of.].
Lamberto Manzoli, Fabio Mascella, Marina Fratini, Alberto Deales, Massimiliano Panella

Ig Sanita Pubbl· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does early arthritis clinic organisation improve outcomes? What evidence is there? A systematic review.
Marcello Govoni, Carlo Alberto Sciré, Maria Manara, Nazzarena Malavolta, Luana Mancarella, Fabio Mascella

Clin Exp Rheumatol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis